Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 1
2012 1
2014 3
2015 2
2016 2
2018 3
2019 5
2020 6
2021 4
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation.
Malek R, Simakov A, Davis A, Maj M, Bernard PJ, Wnorowski A, Martin H, Marco-Contelles J, Chabchoub F, Dallemagne P, Rochais C, Jozwiak K, Ismaili L. Malek R, et al. Among authors: davis a. Molecules. 2022 Dec 22;28(1):71. doi: 10.3390/molecules28010071. Molecules. 2022. PMID: 36615267 Free PMC article.
De novo design of a non-local β-sheet protein with high stability and accuracy.
Marcos E, Chidyausiku TM, McShan AC, Evangelidis T, Nerli S, Carter L, Nivón LG, Davis A, Oberdorfer G, Tripsianes K, Sgourakis NG, Baker D. Marcos E, et al. Among authors: davis a. Nat Struct Mol Biol. 2018 Nov;25(11):1028-1034. doi: 10.1038/s41594-018-0141-6. Epub 2018 Oct 29. Nat Struct Mol Biol. 2018. PMID: 30374087 Free PMC article.
Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents.
Antonijevic M, Charou D, Davis A, Curel T, Valcarcel M, Ramos I, Villacé P, Claeysen S, Dallemagne P, Gravanis A, Charalampopoulos I, Rochais C. Antonijevic M, et al. Among authors: davis a. Molecules. 2024 Jan 19;29(2):515. doi: 10.3390/molecules29020515. Molecules. 2024. PMID: 38276593 Free PMC article.
Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer's disease.
Toublet FX, Lalut J, Hatat B, Lecoutey C, Davis A, Since M, Corvaisier S, Freret T, Sopková-de Oliveira Santos J, Claeysen S, Boulouard M, Dallemagne P, Rochais C. Toublet FX, et al. Among authors: davis a. Eur J Med Chem. 2021 Jan 15;210:113059. doi: 10.1016/j.ejmech.2020.113059. Epub 2020 Dec 3. Eur J Med Chem. 2021. PMID: 33310288
Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease.
Chrétien B, Jourdan JP, Davis A, Fedrizzi S, Bureau R, Sassier M, Rochais C, Alexandre J, Lelong-Boulouard V, Dolladille C, Dallemagne P. Chrétien B, et al. Among authors: davis a. Br J Clin Pharmacol. 2021 Jul;87(7):2830-2837. doi: 10.1111/bcp.14690. Epub 2020 Dec 23. Br J Clin Pharmacol. 2021. PMID: 33274491 Free article.
26 results